Preoperative performance status predicts outcome following heated intraperitoneal chemotherapy

American Journal of Surgery

Volumn 196, Issue 6, 2008, Pages 909-914

  Reuter, Nathaniel P ^a   MacGregor, Jay M ^b   Woodall, Charles E ^a   Sticca, Robert P ^b   William, C ^d   Helm, M B ^c   Scoggins, Charles R ^a   McMasters, Kelly M ^a   Martin, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

Complication; Cytoreduction; Heated intraperitoneal chemotherapy; HIPEC; Performance status; Peritoneal carcinomatosis

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT;

ABDOMINAL ABSCESS; ABSCESS DRAINAGE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SIZE; CARCINOMATOUS PERITONITIS; CAUTERIZATION; CLINICAL ARTICLE; COLON ADENOCARCINOMA; CYTOREDUCTION; DIALYSIS; HEATED INTRAPERITONEAL CHEMOTHERAPY; HUMAN; KAPLAN MEIER METHOD; KIDNEY FAILURE; LENGTH OF STAY; MORBIDITY; OUTCOME ASSESSMENT; PERIOPERATIVE COMPLICATION; PERITONEUM PSEUDOMYXOMA; PLEURA EFFUSION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL RATE; WOUND INFECTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; INJECTIONS; MIDDLE AGED; PERITONEAL CAVITY; PERITONEAL NEOPLASMS; PREOPERATIVE CARE; PSEUDOMYXOMA PERITONEI; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 57449099725     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2008.06.037     Document Type: Article

References (20)

1. Sadeghi B., Arvieux C., Glehen O., et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88 (2000) 358-363
2. Sugarbaker P.H. Peritoneal carcinomatosis: drugs and diseases (1996), Springer-Verlag, New York
3. Elias D., Blot F., El Otmany A., et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92 (2001) 71-76
4. Witkamp A.J., de Bree E., Kaag M.M., et al. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 37 (2001) 979-984
5. McQuellon R.P., Loggie B.W., Lehman A.B., et al. Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 10 (2003) 155-162
6. Pilati P., Mocellin S., Rossi C.R., et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 10 (2003) 508-513
7. Portilla A.G., Sugarbaker P.H., and Chang D. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: Analysis of prognostic features. World J Surg 23 (1999) 23-29
8. Sugarbaker P.H., and Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6 (1999) 727-731
9. Verwaal V.J., van Ruth S., de Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21 (2003) 3737-3743
10. Shen P., Hawksworth J., Lovato J., et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 11 (2004) 178-186
11. Yan T.D., Links M., Fransi S., et al. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy-a journey to becoming a nationally funded peritonectomy center. Ann Surg Oncol 14 (2007) 2270-2280
12. Sugarbaker P.H., Alderman R., Edwards G., et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 13 (2006) 635-644
13. Levine E.A., Stewart J.H., Russell G.B., et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg 204 (2007) 943-953
14. Verwaal V.J., van Tinteren H., Ruth S.V., et al. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 85 (2004) 61-67
15. Loungnarath R., Causeret S., Bossard N., et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum 48 (2005) 1372-1379
16. Kusamura S., Younan R., Baratti D., et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 106 (2006) 1144-1153
17. Gusani N.J., Cho S.W., Colovos C., et al. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol 15 (2008) 754-763
18. Glehen O., Osinsky D., Cotte E., et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: Morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10 (2003) 863-869
19. Roviello F., Marrelli D., Neri A., et al. Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg 30 (2006) 2033-2040
20. Elias D., Goere D., Blot F., et al. Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol 14 (2007) 1818-1824